Yinglu Zhou

9PUBLICATIONS
103CO-AUTHORS
Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2026
Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

|Mar 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.

Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir

|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

James T Yoon, Yinglu Zhou, Mariia Mikhaleva

|Jan 01, 2024
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.

Inhye E Ahn, Danielle M Brander, Yue Ren

|Feb 24, 2023
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.

William Butler, Colin McDowell, Qing Yang

|Jan 30, 2023
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.

Christine E Ryan, Danielle M Brander, Paul M Barr

Pageof 2

Frequent Collaborators

4 joint publications

Svitlana Tyekucheva

3 joint publications

Jennifer R Brown

2 joint publications

Jiaoti Huang

2 joint publications

Erin M Parry